outlook quarter updat estim
zimmer report stronger-than-expect result tuesday morn beat
street top line met consensu ep sale
organ beat strength across board us
upsid asia-pac benefit stock hip set upsid
off-set soft lower gross margin
higher sg lead in-lin cash ep despit strong
manag guidanc look conserv sale guidanc
organ line forecast organ
street estim ep guidanc
forecast street
manag guidanc factor anticip step-down
market growth partial caus pull-forward procedur
headwind one less sell day de-stock asia-
pac stock particularli hip quarter
uk hospit put elect procedur january/februari deal
flu
ep guidanc reflect increas spend vs street
expect call manag widen gm guidanc
rang full year gm expect start bottom end
rang improv cours year
call preview street margin assumpt gm
om fail account higher cost inventori new ceo
plan acceler spend line manag also call
expect tax rate line model
year lower estim reflect longer tail
top-lin headwind increment spend model sale
report organ ep
organ prior model organ growth knee
hip set continu model year dental
spine gener optimist move
year model revenu declin organ
grow organ year
page analyst certif import disclosur
 morgan seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report singl
factor make invest decis
assum slower top-lin recoveri coupl increment spend
 focu debt paydown alongsid addit spend
north campu manag quantifi first time compens
catch-up hit compani sg line increas invest
growth also hit sg line near-term opportun
buildout commerci organ increas special
set supplement increas spend long-term opportun zimmer plan
dedic vast major toward debt paydown
assum share buy-back increment dilut rise
share count take ep
expect zimmer recoveri start momentum increas
new product gain steam stop-gap spend measur begin
wind suppli avail increas warsaw manag
acceler build-out dedic rep see zimmer enter
new momentum revit portfolio includ cementless
revis iter compani flagship persona knee launch
compani rosa robot knee applic limit launch
transit full launch sidu stem-fre shoulder
compet wright simplic system short-stem market
lead us model sale growth organ ep growth
model real benefit gm improv
start get much meaning capit
alloc forecast modest recoveri hip knee
alongsid return form set new product launch increas
invest special salesforc begin translat growth
 top-lin momentum coupl modest oper leverag
cost relat warsaw remedi begin wind interest
expens also expect drop compani continu pay
debt see ep growth reach compound-annual-growth-rate
invest thesi valuat risk
zimmer enter much prospect turnaround stori
differ time around new manag stori give ad credibl
recogn go take time isnt six-month stori
like three-year stori one think work investor next
first catalyst stori recent hire bryan hanson zimmer
new ceo bryan well known investor highli regard perform
covidien respect leader posit
right ship zimmer bring oper background disciplin
zimmer give investor confid conclus north
campu manufactur qualiti system issu plagu compani
last month potenti turnaround compani
expect hanson acceler compani invest special sale
team work reinvigor product develop enhanc execut
upcom launch see revenu growth begin recov
continu zimmer put warsaw issu behind launch multipl
new product reap earli benefit improv moral increas
invest dedic sale team
share trade discount zimmer larg cap peer see
ampl upsid top-lin begin re-acceler manag
put warsaw suppli issu behind stock per share valu
ep estim forecast step follow
ceo announc signific upsid potenti tap compani
work put warsaw issu behind reacceler top-lin growth improv cash
flow expand margin year-end price target valu share
estim discount group discount
impli upsid potenti current level
risk rate price
risk includ long tail merger dis-synergi owe signific product
custom overlap distributor rep loss non-compet come
manag abil address recent qualiti issu potenti
increment cost address issu share loss knee post launch
stryker mako total knee system
summari financi
cash equival
flow oper activ
o/w chang work capit
flow invest activ
sale
flow financ activ
net chang cash
adj free cash flow firm
compani report morgan estim
note million except per-shar data fiscal year end dec o/w
analyst certif research analyst denot ac cover report certifi multipl research
analyst primarili respons report research analyst denot ac cover within document
individu certifi respect secur issuer research analyst cover research view
express report accur reflect person view subject secur issuer part
research analyst compens directli indirectli relat specif recommend view
express research analyst report korea-bas research analyst list front cover also certifi per
kofia requir analysi made good faith view reflect opinion without undu influenc
